Novel Therapies for the Treatment of HFrEF

Amanda Kitten, Pharm.D., M.S.

Assistant Professor of Pharmacy Practice

University of the Incarnate Word Feik School of Pharmacy

Learning Objectives

Review of clinical trials and demonstrated safety and efficacy research of a variety of novel heart failure medications
Review new agents in the treatment of HFrEF

Activity Description

This program consists of 1 video and downloadable resources in PDF format. To begin, take the ungraded pre-test for the module below. Review the video and handout(s), then complete the post-test ( > 70% within 5 attempts) and evaluation. CPE credit will automatically upload to CPE Monitor (allow 7 days).

Continuing Education Credit

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This online activity is approved for 0.100 CEUs (1.00 contact hour) of continuing education credit. In order to receive 1.00 contact hour of CE credit, the participant must complete the online pre-test (ungraded), watch the included video in its entirety, pass the online post-test ( > 70% within 5 attempts), and complete the online evaluation. Upon successful completion of the course evaluation, continuing pharmacy education credits will automatically be uploaded to CPE Monitor (allow 7 days).

Please make sure NABP profile ID and date of birth (month/year) are entered correctly under learner's profile in this system.

Fee

$10.00

CE Hours

1.00

CE Units

0.100

Activity Type

Knowledge

Novel Therapies for the Treatment of HFrEF

About the Faculty

Amanda Kitten, Pharm.D., M.S.
Assistant Professor of Pharmacy Practice
University of the Incarnate Word Feik School of Pharmacy

Dr. Kitten is an Assistant Professor in the Department of Pharmacy Practice at the University of the Incarnate Word Feik School of Pharmacy. She practices as a clinical pharmacist in the Cardiac Care Unit at University Hospital and in an outpatient cardiology clinic at UT Health San Antonio. Dr. Kitten attended the University of Texas at Austin, where she received her Doctor of Pharmacy degree in 2017 and her Master of Pharmaceutical Sciences in 2019. In conjunction with her master’s degree, Dr. Kitten completed a two-year Pharmacotherapy Residency through The University of Texas at Austin and UT Health San Antonio. Dr. Kitten’s research interests include cardiology and large database analysis.

Disclosure: Dr. Kitten has no relevant financial relationship(s), potential or perceived, with commercial or conflicts of interest to disclose.

Activity Number

0067-0000-21-123-H01-P/T

Release Date: Jun 18, 2021

Credit Expiration Date: Jun 15, 2024

CE Hours

1.00